Immune and molecular biomarkers in a clinical trial of
probiotic therapy in multiple sclerosis: a translational approach
VHIR is seeking an outstanding and highly motivated postdoctoral
researcher to apply for a Marie Sklodowska-Curie Postdoctoral
Fellowship and join the Clinical Neuroimmunology Research Group.
Marie Skłodowska-Curie Actions – Postdoctoral Fellowships (MSCA-PF)
The Marie Skłodowska-Curie Postdoctoral Fellowships (MSCA-PF) are
part of the Horizon Europe programme and support postdoctoral
researchers in developing an original research and innovation
project through international mobility. The programme aims to
strengthen researchers’ careers through excellent science,
international collaboration and interdisciplinary experience, while
fostering integration in both academic and non-academic
environments. The MSCA-PF call is highly competitive and represents
an excellent opportunity to attract international talent and
support researchers in consolidating their scientific careers
through an ambitious mobility-based fellowship. The 2026 call
closes on 09/09/2026 (17:00 Brussels time). For candidates applying
to a European Postdoctoral Fellowship, the fellowship duration is
from 12 to 24 months . Full eligibility details: MSCA Postdoctoral
Fellowships 2026 Background Multiple sclerosis (MS) is a chronic
inflammatory and neurodegenerative disease of the central nervous
system, characterised by demyelination and immune dysregulation.
Emerging evidence highlights the role of gut microbiota as a key
environmental factor influencing MS pathogenesis, through its
interaction with the immune system. Dysbiosis has been consistently
described in MS patients and is associated with pro-inflammatory
immune responses. Preclinical studies, including those performed by
our group, demonstrate that probiotic administration can modulate
immune responses, reduce neuroinflammation, and improve disease
severity in experimental models. However, the mechanisms underlying
these ef